For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
The insider’s guide to vaping
Wednesday 14 September 2022, 04:30 AM

Vaping is so “cool”, but long-term effects are yet to be understood [image: Chiara Summer on Unsplash]
Virginia McMillan considers the rise and rise in a few short years of e-cigarettes
Here we are today with the public barely acknowledging the potential risks of vaping
Back in 2014 – was it really only eight years ago? – I inter
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.